U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933524) titled 'Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors' on April 04.
Brief Summary: The purpose of this study is to evaluate the safety and tolerability of ATB-320 in patients with progressive or metastatic solid tumors
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
DRUG: ATB-320
IV infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Autotelicbio
Published by HT Digital Content Services with permission from Health Daily Digest....